You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acquired Immunodeficiency Syndrome Virus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus Infection, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

Not yet recruiting
  • Human Immunodeficiency Virus Infection
  • +2 more
  • Patient Participation Form
  • (no location specified)
Mar 3, 2023

Chikungunya Virus Infection Trial (VLA1553)

Not yet recruiting
  • Chikungunya Virus Infection
  • VLA1553
  • (no location specified)
Aug 31, 2023

Gut Microbiome in People Living With HIV and HBV

Not yet recruiting
  • Human Immunodeficiency Virus
  • +2 more
    • (no location specified)
    Nov 8, 2023

    HIV Trial (Information, motivation, behavioral skills treatment arm, Information only control arm)

    Not yet recruiting
    • HIV
    • Information, motivation, behavioral skills treatment arm
    • Information only control arm
    • (no location specified)
    Oct 18, 2023

    HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)

    Not yet recruiting
    • HIV
    • +2 more
    • Prebiotic
    • Probiotic
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Oct 30, 2023

    HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

    Not yet recruiting
    • HIV-1
    • +3 more
    • (no location specified)
    Jan 17, 2023

    HIV, Aging Trial in Winston-Salem (Customized activity plan, Customized nutrition plan)

    Not yet recruiting
    • HIV
    • Aging
    • Customized activity plan
    • Customized nutrition plan
    • Winston-Salem, North Carolina
      Atrium Health Wake Forest Baptist
    May 12, 2023

    Alcohol Use Disorder, Human Immunodeficiency Virus Trial in Chicago (10 day prebiotic consumption)

    Not yet recruiting
    • Alcohol Use Disorder
    • Human Immunodeficiency Virus
    • 10 day prebiotic consumption
    • Chicago, Illinois
      Ali Keshavarzian
    Nov 14, 2023

    Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

    Not yet recruiting
    • Human Immuno-deficiency Virus (HIV) Disease
    • (no location specified)
    Sep 5, 2023

    HIV Trial (Fostemsavir)

    Available
    • HIV Infections
    • (no location specified)
    Jun 13, 2022

    Human Immunodeficiency Virus Trial run by the CC (Placebo, Pembrolizumab)

    Recruiting
    • Human Immunodeficiency Virus
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    HPV Infection, Sexually Transmitted Infections and Anal

    Not yet recruiting
    • Human Papillomavirus Infection
    • +2 more
      • (no location specified)
      Aug 1, 2023

      Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)

      Not yet recruiting
      • Human Immunodeficiency Virus
      • HIV
      • (no location specified)
      Oct 13, 2022

      Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)

      Recruiting
      • Human Immunodeficiency Virus
      • brentuximab vedotin
      • +2 more
      • Chicago, Illinois
        University of Illinois at Chicago
      Jul 29, 2022

      Human Immunodeficiency Virus Trial in Winston-Salem (Navigators (peer navigator) training, delayed-intervention)

      Not yet recruiting
      • Human Immunodeficiency Virus
      • Navigators (peer navigator) training
      • delayed-intervention
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      Nov 14, 2023

      Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco Trial in Boston, Chennai (Varenicline, Positively Smoke Free

      Not yet recruiting
      • Human Immunodeficiency Virus
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Mar 13, 2023

      HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)

      Completed
      • HIV-1-infection
      • BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
      • Madrid, Spain
        Hospital FUNDACIÓN JIMÉNEZ DÍAZ
      Nov 2, 2022

      Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)

      Recruiting
      • Human Immunodeficiency Virus
      • Opioid Use Disorder
      • Combined LAI Treatment: Cabenuva and Sublocade
      • Providence, Rhode Island
        Rhode Island Hospital
      Aug 7, 2023

      HIV Trial (DTG/3TC)

      Not yet recruiting
      • HIV
      • (no location specified)
      Jun 9, 2023

      HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

      Enrolling by invitation
      • HIV
      • Antiretroviral Therapy Interruption(ATI)
      • Washington, District of Columbia
      • +1 more
      Sep 12, 2022

      Human Immunodeficiency Virus (HIV), Hepatitis C (HCV) Trial in New York (Video Format, Health Educator)

      Not yet recruiting
      • Human Immunodeficiency Virus (HIV)
      • Hepatitis C (HCV)
      • Video Format
      • Health Educator
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jul 21, 2023

      Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)

      Active, not recruiting
      Has Results
      • Human Immunodeficiency Virus (HIV)
      • Doravirine, Tenofovir, Lamivudine
      • +2 more
      • (no location specified)
      Sep 1, 2022

      Human Immunodeficiency Virus Trial (MK-8527)

      Not yet recruiting
      • Human Immunodeficiency Virus
      • (no location specified)
      Aug 8, 2022

      Human Immunodeficiency Virus Trial in Dengkil (PREM-Kit)

      Not yet recruiting
      • Human Immunodeficiency Virus
      • PREM-Kit
      • Dengkil, Selangor, Malaysia
        Universiti Teknologi MARA (Dengkil Campus)
      Nov 13, 2022

      Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)

      Recruiting
      • Human Immunodeficiency Virus
      • +2 more
      • Seattle, Washington
        UW Positve Research, Harborview Medical Center
      May 8, 2023